Richard C. Shelton
Vanderbilt University Medical Center
Department of Psychiatry
1500 21st Avenue
South
Name/email consistency: high
- Agomelatine for the treatment of major depressive disorder. Carney, R.M., Shelton, R.C. Expert. Opin. Pharmacother (2011)
- Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression. Shelton, R.C., Miller, A.H. Prog. Neurobiol. (2010)
- Elevated 5-HT 2A receptors in postmortem prefrontal cortex in major depression is associated with reduced activity of protein kinase A. Shelton, R.C., Sanders-Bush, E., Manier, D.H., Lewis, D.A. Neuroscience (2009)
- Protein kinases A and C in post-mortem prefrontal cortex from persons with major depression and normal controls. Shelton, R.C., Hal Manier, D., Lewis, D.A. Int. J. Neuropsychopharmacol. (2009)
- St John's wort (Hypericum perforatum) in major depression. Shelton, R.C. J. Clin. Psychiatry (2009)
- Long-term management of depression: tips for adjusting the treatment plan as the patient's needs change. Shelton, R.C. J. Clin. Psychiatry (2009)
- Adjunctive use of modafinil in bipolar patients: just another stimulant or not? Shelton, R.C., Reddy, R. Curr. Psychiatry. Rep (2008)
- Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder. Shelton, R.C., Papakostas, G.I. Acta. Psychiatr. Scand (2008)
- Augmentation strategies to increase antidepressant efficacy. Shelton, R.C. J. Clin. Psychiatry (2007)
- The molecular neurobiology of depression. Shelton, R.C. Psychiatr. Clin. North Am. (2007)
- Olanzapine/fluoxetine combination for bipolar depression. Shelton, R.C. Expert. Rev. Neurother (2006)
- The nature of the discontinuation syndrome associated with antidepressant drugs. Shelton, R.C. J. Clin. Psychiatry (2006)
- A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder. Shelton, R.C., Haman, K.L., Rapaport, M.H., Kiev, A., Smith, W.T., Hirschfeld, R.M., Lydiard, R.B., Zajecka, J.M., Dunner, D.L. J. Clin. Psychiatry (2006)
- Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistance. Shelton, R.C., Williamson, D.J., Corya, S.A., Sanger, T.M., Van Campen, L.E., Case, M., Briggs, S.D., Tollefson, G.D. J. Clin. Psychiatry (2005)
- Differential expression of pentraxin 3 in fibroblasts from patients with major depression. Shelton, R.C., Liang, S., Liang, P., Chakrabarti, A., Manier, D.H., Sulser, F. Neuropsychopharmacology (2004)
- The dual-action hypothesis: does pharmacology matter?. Shelton, R.C. J. Clin. Psychiatry (2004)
- Risperidone and paroxetine given singly and in combination for bipolar depression. Shelton, R.C., Stahl, S.M. J. Clin. Psychiatry (2004)
- The use of antidepressants in novel combination therapies. Shelton, R.C. J. Clin. Psychiatry (2003)
- The combination of olanzapine and fluoxetine in mood disorders. Shelton, R.C. Expert. Opin. Pharmacother (2003)